Al-Haddad C, Wehbi Z, Slim A, Hmede A, Jurdi Kheir W, Saab R
Eye (Lond). 2024; 39(4):748-754.
PMID: 39562725
PMC: 11885430.
DOI: 10.1038/s41433-024-03465-8.
Feng Y, Feng X, Lv Y
Ophthalmic Res. 2024; 67(1):672-682.
PMID: 39536726
PMC: 11844715.
DOI: 10.1159/000542193.
Wang D, Chu W, Yam J, Pang C, Leung Y, Shum A
Cancer Metab. 2024; 12(1):31.
PMID: 39462426
PMC: 11515237.
DOI: 10.1186/s40170-024-00361-3.
Nag A, Khetan V
Indian J Ophthalmol. 2024; 72(6):778-788.
PMID: 38804799
PMC: 11232864.
DOI: 10.4103/IJO.IJO_2414_23.
Zhanbo Q, Jing Z, Shugao H, Yinhang W, Jian C, Xiang Y
Aging (Albany NY). 2024; 16(8):6839-6851.
PMID: 38613799
PMC: 11087091.
DOI: 10.18632/aging.205728.
Treatment adherence in retinoblastoma: A retro-prospective cohort study in Ivory Coast and the Democratic Republic of Congo.
Lukamba R, Budiongo A, Monga B, Yao A, Bey P, Chenge G
Cancer Rep (Hoboken). 2023; :e1949.
PMID: 38146612
PMC: 10849925.
DOI: 10.1002/cnr2.1949.
Utility of bone marrow examination in retinoblastoma and their correlation with hematological features.
Yadav G, Singh A, Kushwaha R, Verma N, Srivastava R, Singh U
J Med Life. 2023; 16(8):1245-1250.
PMID: 38024824
PMC: 10652682.
DOI: 10.25122/jml-2023-0156.
Genomic instability and eye diseases.
Liu H, Cheng J, Zhuang X, Qi B, Li F, Zhang B
Adv Ophthalmol Pract Res. 2023; 3(3):103-111.
PMID: 37846358
PMC: 10577848.
DOI: 10.1016/j.aopr.2023.03.002.
State of the Art of Pharmacological Activators of p53 in Ocular Malignancies.
Casciano F, Zauli E, Busin M, Caruso L, AlMesfer S, Al-Swailem S
Cancers (Basel). 2023; 15(14).
PMID: 37509256
PMC: 10377487.
DOI: 10.3390/cancers15143593.
Targeted treatment of solid tumors in pediatric precision oncology.
Bertacca I, Pegoraro F, Tondo A, Favre C
Front Oncol. 2023; 13:1176790.
PMID: 37213274
PMC: 10196192.
DOI: 10.3389/fonc.2023.1176790.
Pediatric Interventional Neuroradiology: Opportunities and Challenges.
Jerele C, Lovric D, Kuhelj D
Children (Basel). 2023; 10(4).
PMID: 37189964
PMC: 10136992.
DOI: 10.3390/children10040715.
miR-4529-3p Promotes the Progression of Retinoblastoma by Inhibiting RB1 Expression and Activating the ERK Signaling Pathway.
Gao Y, Du P
Mol Biotechnol. 2023; 66(1):102-111.
PMID: 37041423
DOI: 10.1007/s12033-023-00738-7.
Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: A narrative review of the literature.
Habibi A, Zarei-Behjani Z, Falamarzi K, Malekpour M, Ebrahimi F, Soleimani M
Front Immunol. 2023; 14:1097456.
PMID: 36969177
PMC: 10033955.
DOI: 10.3389/fimmu.2023.1097456.
Rehabilitation of severe dentofacial deformity after early radiotherapy of retinoblastoma: a case report.
Kim S, Choi T, Lee Y, Kim Y, Jo D, Kim B
J Med Case Rep. 2023; 17(1):103.
PMID: 36895030
PMC: 9997022.
DOI: 10.1186/s13256-023-03761-z.
Value of the strain ratio in the differential diagnosis of intraocular tumors by elastosonography: A retrospective case-control study.
Chen W, Yang W, Li D, Wang Z, Zhao Q, Li Y
Indian J Ophthalmol. 2023; 71(3):983-988.
PMID: 36872722
PMC: 10229935.
DOI: 10.4103/ijo.IJO_1397_22.
BIOMARKERS OF MATERNAL SMOKING AND THE RISK OF RETINOBLASTOMA IN OFFSPRING.
He D, Huang X, Uppal K, Coleman A, Walker D, Ritz B
Retina. 2023; 43(3):481-489.
PMID: 36730579
PMC: 9974849.
DOI: 10.1097/IAE.0000000000003678.
Seasonality of main childhood embryonal tumours and rhabdomyosarcoma, France, 2000-2015.
Awounou D, Lacour B, Desandes E, Guissou S, Cassoux N, Doz F
Cancer Med. 2023; 12(7):8789-8803.
PMID: 36726302
PMC: 10134357.
DOI: 10.1002/cam4.5624.
Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?.
Abdelazeem B, Abbas K, Shehata J, El-Shahat N, Eltaras M, Qaddoumi I
Cancer Med. 2022; 12(5):6318-6324.
PMID: 36479934
PMC: 10028055.
DOI: 10.1002/cam4.5406.
Retinoblastoma: Review and new insights.
Cruz-Galvez C, Ordaz-Favila J, Villar-Calvo V, Cancino-Marentes M, Bosch-Canto V
Front Oncol. 2022; 12:963780.
PMID: 36408154
PMC: 9670800.
DOI: 10.3389/fonc.2022.963780.
Premalignant Conditions of Bone.
Eckhoff M, Wells M, Padilla O, Polfer E, Castagno C, Thabet A
J Am Acad Orthop Surg Glob Res Rev. 2022; 6(10).
PMID: 36227850
PMC: 9575816.
DOI: 10.5435/JAAOSGlobal-D-22-00097.